Logo image of NGLB.DE

ANGLO AMERICAN PLC (NGLB.DE) Stock Fundamental Analysis

FRA:NGLB - Deutsche Boerse Ag - GB00B1XZS820 - Common Stock

30.17  +0.93 (+3.18%)

Fundamental Rating

4

NGLB gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 39 industry peers in the Metals & Mining industry. NGLB has an average financial health and profitability rating. NGLB has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

NGLB had positive earnings in the past year.
NGLB had a positive operating cash flow in the past year.
In the past 5 years NGLB has always been profitable.
NGLB had a positive operating cash flow in each of the past 5 years.
NGLB.DE Yearly Net Income VS EBIT VS OCF VS FCFNGLB.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B -5B 10B 15B

1.2 Ratios

NGLB has a Return On Assets of -2.41%. This is amonst the worse of the industry: NGLB underperforms 80.56% of its industry peers.
Looking at the Return On Equity, with a value of -6.85%, NGLB is doing worse than 80.56% of the companies in the same industry.
NGLB has a better Return On Invested Capital (5.53%) than 75.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NGLB is above the industry average of 6.18%.
The last Return On Invested Capital (5.53%) for NGLB is well below the 3 year average (10.37%), which needs to be investigated, but indicates that NGLB had better years and this may not be a problem.
Industry RankSector Rank
ROA -2.41%
ROE -6.85%
ROIC 5.53%
ROA(3y)6.7%
ROA(5y)5.95%
ROE(3y)16.13%
ROE(5y)14.16%
ROIC(3y)10.37%
ROIC(5y)8.77%
NGLB.DE Yearly ROA, ROE, ROICNGLB.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20

1.3 Margins

NGLB's Profit Margin has declined in the last couple of years.
NGLB has a better Operating Margin (21.93%) than 80.56% of its industry peers.
In the last couple of years the Operating Margin of NGLB has grown nicely.
Looking at the Gross Margin, with a value of 47.18%, NGLB is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
In the last couple of years the Gross Margin of NGLB has grown nicely.
Industry RankSector Rank
OM 21.93%
PM (TTM) N/A
GM 47.18%
OM growth 3Y-6.69%
OM growth 5Y2.3%
PM growth 3Y-51.73%
PM growth 5Y-40.94%
GM growth 3Y-3.67%
GM growth 5Y2.71%
NGLB.DE Yearly Profit, Operating, Gross MarginsNGLB.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so NGLB is still creating some value.
The number of shares outstanding for NGLB remains at a similar level compared to 1 year ago.
Compared to 5 years ago, NGLB has less shares outstanding
Compared to 1 year ago, NGLB has a worse debt to assets ratio.
NGLB.DE Yearly Shares OutstandingNGLB.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B
NGLB.DE Yearly Total Debt VS Total AssetsNGLB.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20B 40B 60B

2.2 Solvency

An Altman-Z score of 2.26 indicates that NGLB is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.26, NGLB is doing good in the industry, outperforming 69.44% of the companies in the same industry.
The Debt to FCF ratio of NGLB is 11.43, which is on the high side as it means it would take NGLB, 11.43 years of fcf income to pay off all of its debts.
NGLB has a better Debt to FCF ratio (11.43) than 63.89% of its industry peers.
A Debt/Equity ratio of 0.72 indicates that NGLB is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.72, NGLB is doing worse than 80.56% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 11.43
Altman-Z 2.26
ROIC/WACC0.61
WACC9.07%
NGLB.DE Yearly LT Debt VS Equity VS FCFNGLB.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B 10B 15B 20B 25B

2.3 Liquidity

A Current Ratio of 1.98 indicates that NGLB should not have too much problems paying its short term obligations.
The Current ratio of NGLB (1.98) is better than 69.44% of its industry peers.
NGLB has a Quick Ratio of 1.33. This is a normal value and indicates that NGLB is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.33, NGLB is doing good in the industry, outperforming 69.44% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.98
Quick Ratio 1.33
NGLB.DE Yearly Current Assets VS Current LiabilitesNGLB.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

1

3. Growth

3.1 Past

The earnings per share for NGLB have decreased strongly by -34.69% in the last year.
NGLB shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.81% yearly.
The Revenue has decreased by -9.91% in the past year.
Measured over the past years, NGLB shows a small growth in Revenue. The Revenue has been growing by 2.11% on average per year.
EPS 1Y (TTM)-34.69%
EPS 3Y-1.35%
EPS 5Y-0.81%
EPS Q2Q%-22.63%
Revenue 1Y (TTM)-9.91%
Revenue growth 3Y6.4%
Revenue growth 5Y2.11%
Sales Q2Q%-8.45%

3.2 Future

NGLB is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -0.17% yearly.
The Revenue is expected to decrease by -0.39% on average over the next years.
EPS Next Y-19.81%
EPS Next 2Y-4.28%
EPS Next 3Y6.54%
EPS Next 5Y-0.17%
Revenue Next Year-9.76%
Revenue Next 2Y-6.18%
Revenue Next 3Y-2.79%
Revenue Next 5Y-0.39%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NGLB.DE Yearly Revenue VS EstimatesNGLB.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B 40B
NGLB.DE Yearly EPS VS EstimatesNGLB.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 14.86 indicates a correct valuation of NGLB.
Compared to the rest of the industry, the Price/Earnings ratio of NGLB indicates a somewhat cheap valuation: NGLB is cheaper than 66.67% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.96, NGLB is valued a bit cheaper.
A Price/Forward Earnings ratio of 14.09 indicates a correct valuation of NGLB.
NGLB's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. NGLB is more expensive than 66.67% of the companies in the same industry.
NGLB's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.11.
Industry RankSector Rank
PE 14.86
Fwd PE 14.09
NGLB.DE Price Earnings VS Forward Price EarningsNGLB.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NGLB is valued a bit cheaper than the industry average as 61.11% of the companies are valued more expensively.
NGLB's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. NGLB is cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 24.4
EV/EBITDA 5.42
NGLB.DE Per share dataNGLB.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

NGLB has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.28%
EPS Next 3Y6.54%

3

5. Dividend

5.1 Amount

NGLB has a Yearly Dividend Yield of 2.66%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.85, NGLB pays a bit more dividend than its industry peers.
NGLB's Dividend Yield is comparable with the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 2.66%

5.2 History

The dividend of NGLB has a limited annual growth rate of 4.94%.
Dividend Growth(5Y)4.94%
Div Incr Years0
Div Non Decr Years0
NGLB.DE Yearly Dividends per shareNGLB.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5 2

5.3 Sustainability

The earnings of NGLB are negative and hence is the payout ratio. NGLB will probably not be able to sustain this dividend level.
DP-70.38%
EPS Next 2Y-4.28%
EPS Next 3Y6.54%
NGLB.DE Yearly Income VS Free CF VS DividendNGLB.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B -5B 10B

ANGLO AMERICAN PLC

FRA:NGLB (1/17/2025, 7:00:00 PM)

30.17

+0.93 (+3.18%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)07-25 2024-07-25/bmo
Earnings (Next)02-20 2025-02-20/amc
Inst Owners73.73%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap40.35B
Analysts77.04
Price Target32.23 (6.83%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.66%
Yearly Dividend1.17
Dividend Growth(5Y)4.94%
DP-70.38%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.45%
PT rev (3m)1.09%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-10.1%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.91%
Revenue NY rev (3m)-2.37%
Valuation
Industry RankSector Rank
PE 14.86
Fwd PE 14.09
P/S 1.41
P/FCF 24.4
P/OCF 5.27
P/B 1.72
P/tB 1.83
EV/EBITDA 5.42
EPS(TTM)2.03
EY6.73%
EPS(NY)2.14
Fwd EY7.1%
FCF(TTM)1.24
FCFY4.1%
OCF(TTM)5.73
OCFY18.99%
SpS21.43
BVpS17.53
TBVpS16.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.41%
ROE -6.85%
ROCE 10.96%
ROIC 5.53%
ROICexc 6.47%
ROICexgc 6.67%
OM 21.93%
PM (TTM) N/A
GM 47.18%
FCFM 5.77%
ROA(3y)6.7%
ROA(5y)5.95%
ROE(3y)16.13%
ROE(5y)14.16%
ROIC(3y)10.37%
ROIC(5y)8.77%
ROICexc(3y)12.05%
ROICexc(5y)10.17%
ROICexgc(3y)12.77%
ROICexgc(5y)10.82%
ROCE(3y)20.56%
ROCE(5y)17.41%
ROICexcg growth 3Y-5.01%
ROICexcg growth 5Y-2.18%
ROICexc growth 3Y-3.75%
ROICexc growth 5Y-1.12%
OM growth 3Y-6.69%
OM growth 5Y2.3%
PM growth 3Y-51.73%
PM growth 5Y-40.94%
GM growth 3Y-3.67%
GM growth 5Y2.71%
F-Score3
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 11.43
Debt/EBITDA 1.84
Cap/Depr 210.47%
Cap/Sales 20.97%
Interest Coverage 8.08
Cash Conversion 83.82%
Profit Quality N/A
Current Ratio 1.98
Quick Ratio 1.33
Altman-Z 2.26
F-Score3
WACC9.07%
ROIC/WACC0.61
Cap/Depr(3y)231.94%
Cap/Depr(5y)209.18%
Cap/Sales(3y)17.19%
Cap/Sales(5y)17.19%
Profit Quality(3y)125.33%
Profit Quality(5y)109.93%
High Growth Momentum
Growth
EPS 1Y (TTM)-34.69%
EPS 3Y-1.35%
EPS 5Y-0.81%
EPS Q2Q%-22.63%
EPS Next Y-19.81%
EPS Next 2Y-4.28%
EPS Next 3Y6.54%
EPS Next 5Y-0.17%
Revenue 1Y (TTM)-9.91%
Revenue growth 3Y6.4%
Revenue growth 5Y2.11%
Sales Q2Q%-8.45%
Revenue Next Year-9.76%
Revenue Next 2Y-6.18%
Revenue Next 3Y-2.79%
Revenue Next 5Y-0.39%
EBIT growth 1Y-15.18%
EBIT growth 3Y-0.72%
EBIT growth 5Y4.46%
EBIT Next Year30%
EBIT Next 3Y16.37%
EBIT Next 5Y7.35%
FCF growth 1Y-75.74%
FCF growth 3Y-36.57%
FCF growth 5Y-33.44%
OCF growth 1Y-40.29%
OCF growth 3Y-0.62%
OCF growth 5Y-1.84%